Virax Biolabs Group Limited (VRAX) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 2.19M |
| Enterprise Value | -3.84M |
| P/E Ratio | -0.11 |
| PEG Ratio | -0 |
| Price/Sales Ratio | 35.51 |
| Price/Book Ratio | 0.14 |
| Enterprise/Revenue | -393.86 |
| Enterprise/EBITDA | 0.7 |
Fiscal Year
| Fiscal Year | March 31, 2026 |
| Most Recent Quarter | March 31, 2026 |
Profitability
| Profit Margin | -524.73 |
| Operating Margin | -640.38 |
AD
Management Effectiveness
| Return On Assets | -0.88 |
| Return On Equity | -1.14 |
Income Statement
| Revenue | 12,423 |
| Revenue/Share | 0.04 |
| Gross Profit | 7,690 |
| EBITDA | -5.43M |
| Net Income | -5.02M |
| Diluted EPS | -12.64 |
Balance Sheet
| Total Cash | 6.52M |
| Total Cash/Share | 16.39 |
| Total Debt | 414,387 |
| Total Debt/Equity | 0.05 |
| Current Ratio | 9.97 |
| Book Value Per Share | 18.45 |
Price History
| 52-Week Change | -82.08 |
| 52-Week High | 21.75 |
| 52-Week Low | 2.5 |
| Moving Average 50 Days | 3.13 |
| Moving Average 200 Days | 5.39 |
Statistics
| Average Volume | 1.83M |
| Shares Outstanding | 19.92M |
| % Held by Institutions | 9.25 |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:25 |
| Last Split Date | June 26, 2026 |
AD
